Southern Cross Pharma
- Company typePrivate
- Founded2000
- HeadquartersHawthorn, Australia
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
Southern Cross Pharma firmographics
Firmographics- Name
- Southern Cross Pharma
- Legal name
- Generic Health
- Website
- https://southernxp.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Southern Cross Pharma industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (4242)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Generic Hospital & Institutional Products (HLAIABAL)
- akta.pro secondary industries
- Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Retail & Community Pharmacies (Chain/Independent) (HLAFALAA)
Keywords
Where Southern Cross Pharma is headquartered
LocationHeadquarters
- HQ city
- Hawthorn
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Southern Cross Pharma business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Distribution channels3 records
Marketing channels2 records
Southern Cross Pharma product offering
Product offeringCore offering
Southern Cross Pharma (operating as Generic Health and now trading as Lupin AU) manufactures and distributes a portfolio of high-quality generic prescription medicines, injectable medicines, and over-the-counter (OTC) medicines in Australia. The company sells its products under multiple brands including Generic Medicine (prescription generics), Pharmacy Action (OTC), Goanna (active lifestyle products with 100+ year heritage), and Minoxidil (hair loss treatments), supplying Australian pharmacies, hospitals, healthcare facilities, and prescribers.
Product overview
Southern Cross Pharma (trading as Generic Health and now Lupin AU) operates as a pharmaceutical company offering a portfolio of quality generic and branded medicines. The product portfolio includes Generic Medicine (prescription generics focused on affordability), Pharmacy Action (OTC medicines), Goanna (active lifestyle products with 100+ year heritage), Minoxidil (hair loss treatments), and Hospital/Injectable products. The company positions itself as a provider of high-quality generic prescription, injectable, and over-the-counter medicines committed to increasing access to quality and affordable medications for Australians.
Differentiator
Problem solved
Functional benefit
Brands
- Generic Medicine: Generic prescription medicines focused on affordability and quality
- Pharmacy Action
- Goanna
- Minoxidil
Products and services
- Generic Medicine Generic prescription medicines offering affordable, quality-assured alternatives to branded pharmaceuticals for Australian patients, pharmacies, and prescribers.
- Pharmacy Action Over-the-counter medicines brand providing everyday medicines consumers rely on, distributed through Australian pharmacies.
- Goanna Heritage brand of products serving active Australians for over 100 years, covering pain relief, first aid, and active-lifestyle health categories.
- Minoxidil Minoxidil-based hair loss treatment products for Australian consumers experiencing hair loss.
- Hospital Injectables and Generic Medicines Injectable and generic medicines supplied directly to hospitals and healthcare facilities for use in clinical and inpatient settings.
Companies that use Southern Cross Pharma
Customer profileSegments4 records
Ideal customer profiles3 records
Southern Cross Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Southern Cross Pharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Lupin AUcoreGeneric Health is now trading as Lupin AU. The company has been acquired or rebranded under the Lupin pharmaceutical group brand. Lupin is a major global pharmaceutical company.
Scale indicators1 record
Recent moves4 records
Expansion highlights5 records
Southern Cross Pharma competitors and assessment
Company assessmentDirect peers
- Apotex (Australia): Canadian-headquartered generic pharmaceutical manufacturer with Australian operations. Competes directly with Southern Cross Pharma in generic prescription medicines and injectable supply to hospitals and pharmacies.
- Arrow Pharmaceuticals (Australia): Australian generic pharmaceutical company offering prescription generics, OTC, and consumer health products distributed through pharmacies. Direct competitor in the Australian pharmacy distribution channel.
- Viatris (formerly Mylan/Upjohn, Australia): Major global generic and branded pharmaceutical company with significant Australian presence. Direct competitor in generic prescription and OTC categories serving pharmacies, hospitals, and prescribers.
- Dr. Reddy's Laboratories Australia: Indian multinational generic pharmaceutical company with Australian operations. Competes in generic prescription medicines and OTC categories, with similar distribution through pharmacies and hospitals.
- Aspen Pharmacare Australia: Australian subsidiary of South African Aspen Pharmacare, supplying generic and specialty pharmaceutical products including injectables to hospitals and pharmacies. Competes directly in similar product categories.
- Teva Pharmaceuticals Australia: Global generic pharmaceutical giant with Australian operations. Competes directly across generic prescription medicines and OTC categories through pharmacy and hospital channels.
- Sandoz (Australia/NZ): Global generic pharmaceutical leader with established Australian operations. Competes directly with Southern Cross Pharma in generic prescription, OTC, and hospital injectable segments across the same channels.
- Alphapharm (Mylan/Viatris subsidiary): Australia's largest generic prescription medicine supplier. Direct competitor in generic prescription generics distributed through pharmacies and PBS channels.
- Aurobindo Pharma Australia: Indian generic pharmaceutical manufacturer with Australian distribution. Competes in generic prescription and OTC categories, similar to Southern Cross Pharma's broader portfolio.
Emerging players
- Cipla Australia: Indian multinational Cipla's Australian subsidiary focused on respiratory, generics, and OTC products. Comparable in offering generic and OTC medicines through Australian pharmacy channels.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Southern Cross Pharma social profiles
Digital presenceSouthern Cross Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Southern Cross Pharma leadership team
Management profileNumber of profiles
Southern Cross Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Southern Cross Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Southern Cross Pharma
What does Southern Cross Pharma do?
Southern Cross Pharma (operating as Generic Health and now trading as Lupin AU) manufactures and distributes a portfolio of high-quality generic prescription medicines, injectable medicines, and over-the-counter (OTC) medicines in Australia. The company sells its products under multiple brands including Generic Medicine (prescription generics), Pharmacy Action (OTC), Goanna (active lifestyle products with 100+ year heritage), and Minoxidil (hair loss treatments), supplying Australian pharmacies, hospitals, healthcare facilities, and prescribers.
Is Southern Cross Pharma a public or private company?
Southern Cross Pharma is a private company. It is classified as corporate owned and is currently operating.
When was Southern Cross Pharma founded?
Southern Cross Pharma was founded in 2000. It employs 11 to 50 people.
Where is Southern Cross Pharma based?
Southern Cross Pharma is headquartered in Hawthorn, Australia, in the Oceania region.
Who are Southern Cross Pharma's main competitors?
Direct peers on record are Apotex (Australia), Arrow Pharmaceuticals (Australia), Viatris (formerly Mylan/Upjohn, Australia), Dr. Reddy's Laboratories Australia, Aspen Pharmacare Australia, Teva Pharmaceuticals Australia, Sandoz (Australia/NZ), Alphapharm (Mylan/Viatris subsidiary) and Aurobindo Pharma Australia. Cipla Australia is listed as an emerging player.
Does Southern Cross Pharma have an API?
No public API is recorded for Southern Cross Pharma.
What industry is Southern Cross Pharma in?
Southern Cross Pharma's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant). Its NAICS code is 325412 and its SIC code is 2834.